Proven Effectiveness

of enteral nutrition

Fresubin Health economics

Prescription and reimbursement

All Fresubin and disease-specific products are food for special medical purposes for the dietary management of patients with or at risk of disease-related malnutrition. Food for medical purposes has to be used under medical supervision and you, the healthcare professional, will define the individual requirements of your patient.
As the effectiveness of ONS and tube feeds are scientifically proven, you can prescribe Fresubin for it to be reimbursed by the health insurance.

 

The evidence for the economic benefits of EN is shown in several cases:

 

CostSavings due ONS Compliance.pdf

Increased compliance with ONS achieves cost savings from up to 12 % in hospitals.

Filename
CostSavings due ONS Compliance.pdf
Size
373 KB
Format
pdf

CostSavings from EN tube feeding.pdf

Enteral tube feeds can reduce the overall resources required to care for a patient.

Filename
CostSavings from EN tube feeding.pdf
Size
1 MB
Format
pdf

CostSavings in EN for Diabetes.pdf

Nutrition support for malnourished patients with impaired glucose tolerance reduces overall costs by improving nutritional status.

Filename
CostSavings in EN for Diabetes.pdf
Size
845 KB
Format
pdf

CostSavings Evidence for EN in ICU.pdf

 

Early enteral nutrition can provide € 5,330 savings per ICU patient when properly managed.

 

Filename
CostSavings Evidence for EN in ICU.pdf
Size
3 MB
Format
pdf

CostSavings in ICU.pdf

Reaching nutritional targets with early enteral nutrition in the ICU lowers costs by reducing major cost factors.

Filename
CostSavings in ICU.pdf
Size
392 KB
Format
pdf

For legal reasons, the following information is intended for medical professionals only. If you are not a healthcare professional, you will be redirected to the appropriate consumer page.